Literature DB >> 24871203

Total flavonoids of litsea coreana enhance the cytotoxicity of oxaliplatin by increasing gap junction intercellular communication.

Bin-bin Yu1, Shu-ying Dong, Mei-ling Yu, Guo-Jun Jiang, Jie Ji, Xu-hui Tong.   

Abstract

Oxaliplatin is widely used in the treatment of variety of cancers, including cancer of the testis and colorectum. Gap junctions (GJs) can amplify the cytotoxicity of antinoeoplastic drugs through the bystander effect in different cancer cells. In this study, we demonstrate that total flavonoids of litsea coreana (TFLC), one extract from the dried leaves of litsea coreana leve, increase the cytotoxicity of oxaliplatin in mouse testicular cancer I-10 cells. We found that cell survival was substantially decreased only when functional GJs formed in I-10 cells. TFLC increased oxaliplatin cytotoxity (inducing cell death and apoptosis) by enhancing gap junction intercellular communication (GJIC) through elevated Cx43 protein expression. Furthermore, apoptosis-related protein (Bax, Bcl-2, caspase-3/9) results showed that the Bax/Bcl-2 ratio and activated caspase-3/9 increased when TFLC was used compared with treatment with oxaliplatin alone, which suggests that the mechanism of increased oxaliplatin-induced apoptosis was through the mitochondrial pathway. These results demonstrate that TFLC can enhance the cytotoxicity of oxaliplatin, and that these processes may be regulated in testicular tumor cells through GJ-mediated regulation of tumor cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871203     DOI: 10.1248/bpb.b14-00193

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Connexin 43 enhances paclitaxel cytotoxicity in colorectal cancer cell lines.

Authors:  Siqi Wang; Shiwu Zhang; Zhenying Zhao; Chunze Zhang; Xiaoyun Yang; Yijia Wang
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

2.  Influence of gap junction intercellular communication composed of connexin 43 on the antineoplastic effect of adriamycin in breast cancer cells.

Authors:  Guojun Jiang; Shuying Dong; Meiling Yu; Xi Han; Chao Zheng; Xiaoguang Zhu; Xuhui Tong
Journal:  Oncol Lett       Date:  2016-12-07       Impact factor: 2.967

Review 3.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

4.  Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation.

Authors:  Yijia Wang; Chunze Zhang; Shiwu Zhang; Zhenying Zhao; Jiawen Wang; Jiali Song; Yue Wang; Jun Liu; Shaobin Hou
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

5.  Chronic Intake of Green Propolis Negatively Affecting the Rat Testis.

Authors:  Grasiela Dias de Campos Severi-Aguiar; Suellen Josine Pinto; Cristina Capucho; Camila Andrea Oliveira; Maria Aparecida Diamante; Renata Barbieri; Fabrícia Souza Predes; Heidi Dolder
Journal:  Pharmacognosy Res       Date:  2017 Jan-Mar

6.  Pattern of cell-to-cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells.

Authors:  Yuexia Peng; Xiyan Wang; Yunquan Guo; Fuhua Peng; Ningze Zheng; Bo He; Hui Ge; Liang Tao; Qin Wang
Journal:  Cancer Sci       Date:  2019-06       Impact factor: 6.716

7.  Connexin43 Suppresses Lung Cancer Stem Cells.

Authors:  Randall J Ruch
Journal:  Cancers (Basel)       Date:  2019-02-02       Impact factor: 6.639

Review 8.  A review on phytochemical and pharmacological properties of Litsea coreana.

Authors:  Xuejing Jia; Peng Li; Jianbo Wan; Chengwei He
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

9.  Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway.

Authors:  Deng-Pan Wu; Yan Zhou; Li-Xiang Hou; Xiao-Xiao Zhu; Wen Yi; Si-Man Yang; Tian-Yu Lin; Jin-Lan Huang; Bei Zhang; Xiao-Xing Yin
Journal:  Int J Biol Sci       Date:  2021-06-11       Impact factor: 10.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.